Yusuke Higuchi Selected Research

Yusuke Higuchi Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 04/2016
4	Fibrosis (Cirrhosis) 01/2024 - 01/2011
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 01/2015
4	Chronic Renal Insufficiency 12/2017 - 12/2010
3	COVID-19 03/2023 - 01/2023
3	Infections 03/2023 - 01/2022
2	Pulmonary Hypertension 01/2024 - 06/2023
2	Heart Failure 10/2023 - 12/2017
2	Lymphoma (Lymphomas) 09/2023 - 01/2022
2	Hypoxia (Hypoxemia) 06/2023 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 01/2021
2	Infarction (Infarctions) 01/2022 - 01/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 01/2017
2	Inflammation (Inflammations) 01/2020 - 06/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 08/2016 - 03/2011
2	Atherosclerosis 06/2013 - 12/2010
1	Cognitive Dysfunction 01/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Disease Progression 11/2023
1	Hemorrhagic Shock 11/2023
1	Multiple Myeloma 09/2023
1	Febrile Neutropenia 09/2023
1	Fatty Liver 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Hepatitis 01/2023
1	Reperfusion Injury 01/2022
1	Edema (Dropsy) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Hypothermia 01/2022
1	Obesity 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Diabetes Mellitus 12/2017
1	Starvation 12/2017
1	Intestinal Volvulus (Volvulus) 10/2017
1	Hodgkin Disease (Hodgkin's Disease) 05/2017
1	Bone Fractures (Bone Fracture) 10/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2011
3	IndicanIBA 06/2013 - 12/2010
2	CateninsIBA 01/2024 - 01/2024
2	ICG 001IBA 01/2024 - 01/2024
2	Monoclonal AntibodiesIBA 03/2023 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 12/2017
2	mogamulizumabIBA 01/2022 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2014
2	14-3-3 Proteins (14-3-3 Protein)IBA 01/2018 - 04/2016
2	Rituximab (Mabthera)FDA Link 08/2016 - 01/2015
1	Caveolin 1IBA 01/2024
1	beta CateninIBA 01/2024
1	ProdrugsIBA 01/2024
1	Messenger RNA (mRNA)IBA 10/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023
1	Cefepime (Maxipime)FDA LinkGeneric 09/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 03/2023
1	cilgavimabIBA 01/2023
1	Digoxin (Digitek)FDA LinkGeneric 01/2023
1	tixagevimabIBA 01/2023
1	AerosolsIBA 01/2023
1	AlpelisibIBA 01/2023
1	fusicoccinIBA 01/2023
1	InterferonsIBA 01/2023
1	LipidsIBA 01/2023
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2022
1	2-methylthiazolineIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	TroponinIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	polatuzumab vedotinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	CytokinesIBA 01/2020
1	Early Growth Response Protein 1IBA 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	KetonesIBA 12/2017
1	Histones (Histone)IBA 12/2017
1	IsotopesIBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	CalciumIBA 12/2017
1	BariumIBA 10/2017
1	Brentuximab VedotinIBA 05/2017
1	NivolumabIBA 05/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Gemcitabine FDA Link 01/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	MagnesiumIBA 10/2016

Therapy/Procedure

8	Therapeutics 11/2023 - 01/2014
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
2	Salvage Therapy 01/2017 - 01/2015
1	Cardiopulmonary Resuscitation (CPR) 11/2023
1	Induced Hypothermia 01/2022